Bank Of America Corp Bria Cell Therapeutics Corp. Transaction History

Bank Of America Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$5.72 - $7.58 $4,862 - $6,443	850 Added 306.86%	1,127 $7,000
Q1 2023 May 12, 2023	BUY	$4.59 - $7.99 $757 - $1,318	165 Added 147.32%	277 $2,000
Q4 2022 Feb 10, 2023	SELL	$4.28 - $6.73 $1,660 - $2,611	-388 Reduced 77.6%	112 $0
Q3 2022 Nov 14, 2022	BUY	$3.0 - $8.31 $1,500 - $4,155	500 New	500 $3,000
Q4 2021 Feb 08, 2022	SELL	$7.1 - $10.61 $2,641 - $3,946	-372 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.4 - $9.28 $96,698 - $203,946	-21,977 Reduced 98.34%	372 $3,000
Q2 2021 Sep 13, 2021	BUY	$2.89 - $6.57 $64,588 - $146,832	22,349 New	22,349 $119,000

Ticker BCTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,518,000
Market Cap $14.9M
Description
BriaCell Therapeutics Corp., an immuno-oncology biotechnology company, engages in developing immunotherapies for the treatment of cancer. Its lead candidate is Bria-IMT that is in Phase I/IIa clinical trial in a combination study with immune checkpoint inhibitors for the treatment of breast cancer. The company also has a cooperative research and...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.